Attitude Towards COVID-19 Vaccine and Affecting Factors in Adults from Turkey

Year 2022, Volume: 6 Issue: 2, 539 - 549, 31.05.2022

Merve Çolak , Rıdvan Doğan , Emel Erdeniz , Ezgi Hasret Kozan , Mert İlhan , Hatice Çolak

https://doi.org/10.30621/jbachs.966367

Cited By: 1

Abstract

Objective: This study aims to examine the attitude towards COVID-19 Vaccine and its affecting factors in adults from Turkey.
Materials and Methods: This cross-sectional study was conducted in February 2021 with a total of 645 adult individuals. The Introductory Information Form, The Scale of Vaccine Hesitancy, and The Attitudes Towards the COVID-19 Vaccine Scale were used to collect the research data. The data were collected online via the snowball sampling method on social media.
Results: 33.8% of the adult individuals participating in the study stated that they would not be vaccinated. The concerns of the participants about getting the COVID-19 vaccine were, in turn, the production of the vaccine in a short time (19.8%), fear of the side effects of the vaccine (18.9%), and not relying on the content of the vaccine (16.2%). The factors affecting the positive attitude towards the COVID-19 vaccine are, in turn, thinking about getting COVID-19 Vaccine, finding it useful to wear a mask, thinking that the source of COVID-19 is natural, being a healthcare professional and not refusing the vaccine in the past.
Conclusions: Public health efforts to reduce the public's negative attitudes and concerns about vaccination are urgent and important.
Keywords: Vaccination Refusal, COVID-19 Vaccines, Anti-Vaccination Movement, Turkey
Amaç: Bu çalışmanın amacı, Türkiye’deki yetişkinlerin Covid-19 aşısına yönelik tutumu ve etkileyen faktörleri incelemektir.
Gereç ve Yöntem: Bu kesitsel çalışma Şubat 2021 tarihlerinde toplam 645 yetişkin birey ile yapılmıştır. Araştırma verilerinin toplanmasında Tanıtıcı Özellikler Formu, Aşı Karşıtlığı Ölçeği ve COVID-19 Aşısına Yönelik Tutumlar Ölçeği kullanılmıştır. Veriler online olarak sosyal medya üzerinden kartopu örneklem yöntemi ile toplanmıştır.
Bulgular: Çalışmaya katılan yetişkin bireylerin %33.8'si aşı yaptırmayacağını belirtti. COVID-19 aşısı yaptırma konusunda katılımcıların kaygıları sırası ile kısa sürede aşının üretilmesi (%19.8), aşının yan etkilerinden korkma (%18.9) ve aşının içeriğine güvenmemeydi (%16.2). Covid-19 aşısına yönelik olumlu tutumu etkileyen faktörler sırası ile Covid-19 Aşısı yaptırmayı düşünme, maske takmayı faydalı bulma, Covid-19’un kaynağının doğal olduğunu düşünme, sağlık çalışanı olma ve geçmişte aşı redetmememiş olmaktır.
Sonuç: Toplumun aşıya yönelik olumsuz tutum ve endişelerini azaltmaya yönelik halk sağlığı çabaları acil ve önemlidir.
Anahtar Kelimeler: Aşı Reddi, Covıd-19 Aşıları, Aşı Karşıtı Hareket, Türkiye

Keywords

Vaccination Refusal, COVID-19 Vaccines, Anti-Vaccination Movement, Turkey

Project Number

yok

References

• 1. Sharpe HR, Gilbride C, Allen E, et al. The early landscape of coronavirus disease 2019 vaccine development in the UK and rest of the world. Immunology. 2020;160(3): 223–232.
• 2. Akarsu B, Canbay Özdemir D, Ayhan Baser D, Aksoy H, Fidancı İ, Cankurtaran M. While studies on COVID-19 vaccine is ongoing, the public’s thoughts and attitudes to the future COVID-19 vaccine. Int J Clin Pract. 2020;75(4).
• 3. Pogue K, Jensen JL, Stancil CK, et al. Influences on attitudes regarding potential covid‐19 vaccination in the united states. Vaccines. 2020;8(4):582.
• 4. World Health Organization. Meeting of the strategic advisory group of experts on immunization, April 2014—conclusions and recommendations. Wkly Epidemiol Rec. 2014;89(21):221–36.
• 5. Salali GD, Uysal MS. COVID-19 vaccine hesitancy is associated with beliefs on the origin of the novel coronavirus in the UK and Turkey. Psychol Med. 2020;1–3.
• 6. Paul E, Steptoe A, Fancourt D. Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. Lancet Reg Heal - Eur. 2021;1(100012).
• 7. Williams L, Gallant AJ, Rasmussen S, et al. Towards intervention development to increase the uptake of COVID-19 vaccination among those at high risk: Outlining evidence-based and theoretically informed future intervention content. Br J Health Psychol. 2020;25(4):1039–54.
• 8. Freeman D, Waite F, Rosebrock L, et al. Coronavirus Conspiracy Beliefs, Mistrust, and Compliance with Government Guidelines in England. Psychol Med. 2020;1–13.
• 9. O’Malley PA. A Looming Threat Within a Pandemic. Clin Nurse Spec. 2021;35(1):11–3.
• 10. Lane S, MacDonald NE, Marti M, Dumolard L. Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015–2017. Vaccine. 2018;36(26):3861–7.
• 11. Aranda S. Ten threats to global health in 2019 [Internet]. World Health Organisation (WHO). 2019 [cited 2021 Mar 8]. Available from: https://www.who.int/vietnam/news/feature-stories/detail/ten-threats-to-global-health-in-2019.
• 12. Kılınçarslan MG, Sarıgül B, Toroman Ç, Şahin EM. Development of Valid and Reliable Scale of Vaccine Hesitancy in Turkish Language. Konuralp Tıp Derg. 2020;12(3):420–9.
• 13. Geniş B, Gürhan N, Koç M, Geniş Ç, Şirin B, Çırakoğlu OC, Coşar B. Development of Perception and Attitude Scales Related with COVID-19 Pandemia. Pearson J Soc Sci - Humanit. 2020;5(7):306–28.
• 14. Murphy J, Vallières F, Bentall RP, et al. Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nat Commun. 2021;12(1):1–15.
• 15. Detoc M, Bruel S, Frappe P, Tardy B, Botelho-Nevers E, Gagneux-Brunon A. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine. 2020 Oct 21;38(45):7002–6.
• 16. Yoda T, Katsuyama H. Willingness to Receive COVID-19 Vaccination in Japan. Vaccines. 2021;9(1):48.
• 17. Ditekemena JD, Nkamba DM, Mutwadi A, et al. COVID-19 Vaccine Acceptance in the Democratic Republic of Congo: A Cross-Sectional Survey. Vaccines. 2021;9(2):153. 18. Bell S, Clarke R, Mounier-Jack S, Walker JL, Paterson P. Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England. Vaccine. 2020;38(49):7789–98.
• 19. Ruiz JB, Bell RA. Predictors of intention to vaccinate against COVID-19: Results of a nationwide survey. Vaccine. 2021 Feb 12;39(7):1080–6.
• 20. Rozbroj T, Lyons A, Lucke J. Psychosocial and demographic characteristics relating to vaccine attitudes in Australia. Patient Educ Couns. 2019;102(1):172–9.
• 21. Kose S, Mandiracioglu A, Sahin S, Kaynar T, Karbus O, Ozbel Y. Vaccine hesitancy of the COVID‐19 by health care personnel. Int J Clin Pract. 2020;75(5):e13917.
• 22. Latkin CA, Dayton L, Yi G, Colon B, Kong X. Mask usage, social distancing, racial, and gender correlates of COVID-19 vaccine intentions among adults in the US. PLoS One. 2021;16(2):e0246970.
• 23. Dodd RH, Cvejic E, Bonner C, et al. Willingness to vaccinate against COVID-19 in Australia. Lancet Infect Dis. 2020;21(3):318–9.
• 24. Karafillakis E, Dinca I, Apfel F, et al. Vaccine hesitancy among healthcare workers in Europe: A qualitative study. Vaccine. 2016;34(1):5013–20.
• 25. Dror AA, Eisenbach N, Taiber S, et al. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. 2020;35(8):775–9.
• 26. Wong LP, Alias H, Wong PF, Lee HY, AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vaccines Immunother. 2020;16(9):2204–14.
• 27. Sallam M, Dababseh D, Eid H, et al. High Rates of COVID-19 Vaccine Hesitancy and Its Association with Conspiracy Beliefs: A Study in Jordan and Kuwait among Other Arab Countries. Vaccines. 2021;9(1):42.
• 28. Twitter. Updates to our work on COVID-19 vaccine misinformation [Internet]. 2020 [cited 2021 Mar 8]. Available from: https://blog.twitter.com/en_us/topics/company/2021/updates-to-our-work-on-covid-19-vaccine-misinformation.html.
• 29. Kuter BJ, Browne S, Momplaisir FM, et al. Perspectives on the receipt of a COVID-19 vaccine: A survey of employees in two large hospitals in Philadelphia. Vaccine. 2021;39(12):1693–700.